Related Experiment Video
Updated: Aug 5, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Menopausal Considerations in Transgender and Gender-Diverse Individuals
Neha Reddy1, Jill Liss2, Andrew R Fisher1
1Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
None:
Assessing and treating menopause in transgender and gender diverse (TGD) individuals is of increasing interest to clinicians providing gender-affirming care. There currently exists a small body of literature that describes cardiovascular, bone health, neurocognitive, and other outcomes in the TGD population who experience loss of endogenous sex hormone production, whether through gender-affirming hormone therapy, surgical gonadectomy, or natural aging. However, the literature is currently insufficient to provide clear evidence-based guidance for the medical management of menopause in TGD individuals. As a result, clinical care largely relies on extrapolation from cisgender populations, expert opinion, clinical consensus, and shared decision-making.
Related Concept Videos
Menopause
Disorders of the Female Reproductive System
Hormonal Regulation
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
